Subclinical hypothyroidism associated with increased risk of congestive heart failure

A hormonal condition known as subclinical hypothyroidism is associated with an increased risk of congestive heart failure among older adults, but not with other cardiovascular events and death, according to a study in the Archives of Internal Medicine.

Subclinical hypothyroidism (SH) refers to patients who have an elevated level of the hormone thyrotropin, also known as thyroid stimulating hormone (TSH), and a normal level of the hormone thyroxine (T4). The prevalence of SH increases with age, and is about ten percent in women over the age of 70, and somewhat lower in men, according to background information in the article. Subclinical hypothyroidism has been associated with higher levels of some cardiovascular risk factors, but data on cardiovascular outcomes and death are limited.

Nicolas Rodondi, M.D., MAS, of the University of California, San Francisco, and colleagues studied 2,730 men and women, aged 70 to 79, to determine whether subclinical hypothyroidism was associated with congestive heart failure (CHF, failure of the heart to pump blood with normal efficiency), coronary heart disease (CHD), stroke, peripheral arterial disease (PAD, partial or total blockage of an artery, usually an artery leading to a leg or arm), death, and cardiovascular-related death. Subclinical hypothyroidism was defined as TSH levels of 4.5-6.9 mIU/L (mild), 7.0-9.9 mIU/L (moderate), and 10 mIU/L or greater (severe).

The authors found that the incidence of CHF during a four-year follow-up period was significantly increased in patients with moderate and severe SH, but not in patients with mild SH, who comprised the highest percentage (68 percent) of all patients with SH in the study.

"In this population-based study of older adults, subclinical hypothyroidism was associated with a higher rate of incident and recurrent CHF among participants with a TSH level of 7.0 mIU/L or greater compared with euthyroid participants [participants with normal thyroid function]," they write. "This association persisted after adjustment for cardiovascular risk factors."

"We found no consistent evidence that subclinical hypothyroidism was associated with CHD events, stroke, PAD, cardiovascular-related mortality, or total mortality," they continue.

"Because no other prospective study has assessed the risk of CHF events in subjects with subclinical hypothyroidism, to our knowledge, our results should be confirmed in other large prospective studies, including those in younger populations," the authors conclude. "Further investigation is also warranted to assess whether subclinical hypothyroidism causes or worsens pre-existing heart failure."

Comments

  1. Bob Bob United Kingdom says:

    http://dx.doi.org/10.2169/internalmedicine.48.1758

    The Effect of Hormone Replacement Treatment on Thrombin-Activatable Fibrinolysis Inhibitor Activity Levels in Patients with Hashimoto Thyroiditis

    Intern Med. 2009;48(5):281-5. Epub 2009 Mar 2.

    Sevki Cetinkalp 1, Mahmut Tobu 2, Muammer Karadeniz 1, Filiz Buyukkeçeci 2
    and Candeger Yilmaz 1

    1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University Hospital, Izmir, Turkey and

    2 Division of Hematology, Department of Internal Medicine,
    Ege University Hospital, Izmir, Turkey
    Received for publication October 7, 2008; Accepted for publication November 11, 2008

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How vitamin B3 could be the secret to living longer and protecting your heart